CombiGene AB's market cap is currently €4.10M. The company's EPS TTM is €-0.055956613999999995; its P/E ratio is ―; CombiGene AB is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
